RUA Life Sciences PLC (RUA)

Industry Medical Devices

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

11.50p

Buy

13.00p

arrow-up0.00p (+0.00%)

Prices updated at 19 Dec 2025, 14:42 GMT

Prices minimum 15 mins delay

Prices in GBX

AorTech International PLC through its subsidiary is engaged in the development, exploitation & commercialization of biomedical polymer technology, components and medical devices.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Geoffrey Alan Berg

CEO

Mr. William Donald Brown

Most recent earnings

31 Mar 2025

Fiscal year end

31 Mar 2025

Employees

40

Head office

2 Drummond Crescent

Irvine

United Kingdom

KA11 5AN

+44 1294317073

info@aortech.net

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Geoffrey Alan Berg Non-Executive Director, Chairman	-
Mr. Ian Leslie Ardill Non-Executive Director	-
Mr. John McKenna Non-Executive Director	-
Mr. John Louis Ely Non-Executive Director	-
Mr. Lachlan Arthur Smith Executive Director, Company Secretary and Group Chief Financial Officer	-
Mr. William Donald Brown Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	33,612
Unicorn AIM VCT Series 3 ORD	33,612
Maven Capital Partners UK LLP	-

Director dealings

Date chevron-l-regular chevron-r-regular	Action
02 May 2025	Purchase
03 Feb 2025	Purchase
03 Feb 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.